Header cover image

French Biotech Breakthroughs

Results

1

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

1 companies

Valneva

Market Cap: €797.2m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

VLA

€4.59

7D

5.6%

1Y

21.5%